Treatment with parathyroid peptides and estrogen replacement for severe postmenopausal vertebral osteoporosis: prediction of long-term responses in spine and femur.

類似資料

• Human parathyroid peptide treatment of vertebral osteoporosis.
  著者:: Reeve, J, 等
  出版事項: (1993)
• Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
  著者:: Reeve, J, 等
  出版事項: (1987)
• A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
  著者:: Reeve, J, 等
  出版事項: (1986)
• Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
  著者:: Tellez, M, 等
  出版事項: (1995)
• Does the presence of postmenopausal symptoms influence susceptibility to vertebral deformity? European Vertebral Osteoporosis Study (EVOS) Group.
  著者:: Scoutellas, V, 等
  出版事項: (1999)